Literature DB >> 1605332

Assessment factors associated with premature psychotherapy termination.

D H Frayn1.   

Abstract

Characteristics of patients accepted for both intensive psychotherapy and psychoanalysis were rated during their initial assessments. Twenty cases that terminated prematurely (most within the first month) were compared with twenty cases that continued in therapy. While neither specific diagnosis, type of insight therapy, nor gender of the patient or therapist was a reliable predictor of premature termination, it was found that psychodynamic and environmental assessment factors significantly differed between these two groups. In those patients who eventually dropped out, specific ego deficits, primarily introspection, frustration tolerance, impulse control, and motivation, were rated as significantly more impaired. The therapists' negative feelings toward their prospective patients and the patients' hostility toward past caretakers and present life circumstances were also associated with premature termination.

Entities:  

Mesh:

Year:  1992        PMID: 1605332     DOI: 10.1176/appi.psychotherapy.1992.46.2.250

Source DB:  PubMed          Journal:  Am J Psychother        ISSN: 0002-9564


  3 in total

1.  EARLY WITHDRAWAL FROM MENTAL HEALTH TREATMENT: IMPLICATIONS FOR PSYCHOTHERAPY PRACTICE.

Authors:  Marna S Barrett; Wee-Jhong Chua; Paul Crits-Christoph; Mary Beth Gibbons; D Casiano; Don Thompson
Journal:  Psychotherapy (Chic)       Date:  2008-06-01

2.  Early identification of treatment failures in short-term psychotherapy. An assessment of therapeutic alliance and interpersonal behavior.

Authors:  L W Samstag; S T Batchelder; J C Muran; J D Safran; A Winston
Journal:  J Psychother Pract Res       Date:  1998

3.  Drop-out from chronic pain treatment programmes: Is randomization justified in biopsychosocial approaches?

Authors:  Aminata Bicego; Justine Monseur; Floriane Rousseaux; Marie-Elisabeth Faymonville; Nicole Malaise; Irène Salamun; Alain Collinet; Anne-Sophie Nyssen; Audrey Vanhaudenhuyse
Journal:  J Rehabil Med       Date:  2021-04-28       Impact factor: 2.912

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.